Emerging within the UK, retatrutide, a new peptide , is creating considerable buzz within the healthcare community regarding its promise for weight regulation. This dual GIP and GLP-1 receptor agonist appears to deliver a considerable advantage over current therapies, showing encouraging results in preliminary clinical studies . Researchers suggest